Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Citius Pharmaceuticals, Inc. (CTXR) had Debt to Capital Ratio of 0.08 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.49M |
|
$-8.86M |
|
$0.49M |
|
$1.00M |
|
$13.23M |
|
$-11.73M |
|
$-0.29M |
|
$-12.03M |
|
$-12.03M |
|
$-11.92M |
|
$-11.92M |
|
$-11.92M |
|
$-11.92M |
|
$-11.73M |
|
$-9.79M |
|
26.17M |
|
26.17M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$43.33M |
|
-- |
|
$98.92M |
|
$142.26M |
|
$51.65M |
|
$6.41M |
|
$14.70M |
|
$66.35M |
|
$75.91M |
|
$66.56M |
|
$75.91M |
|
27.45M |
|
| Cash Flow Statement Financials | |
$-22.99M |
|
$-7.00M |
|
$42.74M |
|
$4.25M |
|
$17.01M |
|
$12.76M |
|
$11.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.84 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.08 |
0.08 |
|
67.07% |
|
-785.39% |
|
-785.39% |
|
-- |
|
-805.11% |
|
-593.31% |
|
$-22.99M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
2.18 |
|
41.35 |
|
-15.70% |
|
-17.91% |
|
-8.38% |
|
-14.48% |
|
$2.77 |
|
$-0.88 |
|
$-0.88 |
|